Ladenhauf, V.K.; Galijasevic, M.; Kerschbaumer, J.; Freyschlag, C.F.; Nowosielski, M.; Birkl-Toeglhofer, A.M.; Haybaeck, J.; Gizewski, E.R.; Mangesius, S.; Grams, A.E.
Peritumoral ADC Values Correlate with the MGMT Methylation Status in Patients with Glioblastoma. Cancers 2023, 15, 1384.
https://doi.org/10.3390/cancers15051384
AMA Style
Ladenhauf VK, Galijasevic M, Kerschbaumer J, Freyschlag CF, Nowosielski M, Birkl-Toeglhofer AM, Haybaeck J, Gizewski ER, Mangesius S, Grams AE.
Peritumoral ADC Values Correlate with the MGMT Methylation Status in Patients with Glioblastoma. Cancers. 2023; 15(5):1384.
https://doi.org/10.3390/cancers15051384
Chicago/Turabian Style
Ladenhauf, Valentin Karl, Malik Galijasevic, Johannes Kerschbaumer, Christian Franz Freyschlag, Martha Nowosielski, Anna Maria Birkl-Toeglhofer, Johannes Haybaeck, Elke Ruth Gizewski, Stephanie Mangesius, and Astrid Ellen Grams.
2023. "Peritumoral ADC Values Correlate with the MGMT Methylation Status in Patients with Glioblastoma" Cancers 15, no. 5: 1384.
https://doi.org/10.3390/cancers15051384
APA Style
Ladenhauf, V. K., Galijasevic, M., Kerschbaumer, J., Freyschlag, C. F., Nowosielski, M., Birkl-Toeglhofer, A. M., Haybaeck, J., Gizewski, E. R., Mangesius, S., & Grams, A. E.
(2023). Peritumoral ADC Values Correlate with the MGMT Methylation Status in Patients with Glioblastoma. Cancers, 15(5), 1384.
https://doi.org/10.3390/cancers15051384
